Date:
14 Mar 2012, 12:00 - 13:00

Host:
Alan Fairlamb

Simon Croft is of Professor Parasitology and Head of the Faculty of Infectious and Tropical Diseases at the London School of Hygiene and Tropical Medicine, London, UK.  He trained as a parasitologist at the Liverpool School of Tropical Medicine and, after post-doctoral periods in the laboratory researching anti-parasite drug mechanisms and in disease endemic countries working on the transmission of African trypanosomiasis, he moved to research on drug discovery and development.  His expertise and knowledge on anti-parasitic and antimicrobial chemotherapy was developed while working for 5 years with the Wellcome Research Laboratories, Beckenham, UK in the 1980’s.  Following his return to academia, Simon focused his research on the identification and evaluation of novel drugs and formulations for the treatment of leishmaniasis, malaria, human African trypanosiamis (sleeping sickness) and American trypanosiamis (Chagas disease).  This research included projects on miltefosine, AmBisome and topical paromomycin, all of which reached clinical trials for the treatment of leishmaniasis, and many others with academic and private sector partners.  From 2004 to 2007 Simon was the first R & D Director of the Drugs for Neglected Diseases Initiative (DNDi), Geneva.  Current research interests include drug-immune interactions, PK PD relationships in leishmaniasis and trypanosomiasis and development of pharmaceutical formulations for parasitic diseases.

Type of Event:
Seminar

Speaker:
Prof Simon Croft

Location:
MSI Small Lecture Theatre